Bioengineered Models of Solid Human Tumors for Cancer Research

Area of Science:

• Biomedical Engineering
• Oncology
• Tissue Engineering

Background:

• Current in vitro cancer models like cell cultures and animal studies do not fully replicate solid tumor complexity.
• Understanding Ewing sarcoma initiation and progression is hindered by the lack of accurate in vitro models.
• Developing novel therapies for Ewing sarcoma requires more sophisticated preclinical models.

Purpose of the Study:

• To establish a bioengineered in vitro model of Ewing sarcoma that recapitulates key features of the native tumor.
• To create a model that incorporates the bone tumor microenvironment and mechanical signals.
• To provide a more physiologically relevant platform for studying Ewing sarcoma.

Main Methods:

• Infusing Ewing sarcoma cell aggregates into human bone engineered from patient-derived mesenchymal stem cells.
• Utilizing a bioreactor platform to apply physiologically relevant mechanical stimuli.
• Co-culturing tumor cells with osteoblasts and bone-supporting cells within an engineered bone niche.

Main Results:

• The engineered bone niche facilitated crosstalk between tumor cells, bone cells, and the extracellular matrix.
• The model successfully mimicked key properties of the native Ewing sarcoma tumor.
• The bioreactor enabled the incorporation of physical regulatory signals into the in vitro model.

Conclusions:

• This novel tissue-engineered model offers a more accurate in vitro representation of Ewing sarcoma.
• The model provides essential tissue context and physical cues, advancing cancer research.
• This approach has the potential to accelerate the development of new Ewing sarcoma therapies.